{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:38:14Z","timestamp":1783647494902,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02615-9","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:11:03Z","timestamp":1671127863000},"page":"2197-2202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-4837","authenticated-orcid":false,"given":"E\u015fay","family":"K\u0131ran Yenice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-303X","authenticated-orcid":false,"given":"\u0130kbal Seza","family":"Petri\u00e7li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-547X","authenticated-orcid":false,"given":"Caner","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"1","key":"2615_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C (2013) Preterm-associated visual impairment and estimate of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 74(1):35\u201349","journal-title":"Pediatr Res"},{"key":"2615_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J Chen","year":"2007","unstructured":"Chen J, Smith LEH (2007) Retinopathy of prematurity. Angiogenesis 10:133\u2013140","journal-title":"Angiogenesis"},{"key":"2615_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000280386","volume":"98","author":"A Hoogerwerf","year":"2010","unstructured":"Hoogerwerf A, Schalij-Delfos NE, van Schooneveld MJ, Termote JU (2010) Incidence of retinopathy of prematurity over the last decade in the Central Netherlands. Neonatology 98:137\u2013142","journal-title":"Neonatology"},{"key":"2615_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3928\/01913913-20121127-02","volume":"50","author":"G Isaza","year":"2013","unstructured":"Isaza G, Arora S, Bal M, Chaudhary V (2013) Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada. J Pediatr Ophthalmol Strabismus 50:27\u201332","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2615_CR5","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV (2004) Early treatment for retinopathy of prematurity cooperative group final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233\u2013250","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2615_CR6","doi-asserted-by":"publisher","first-page":"e042384","DOI":"10.1136\/bmjopen-2020-042384","volume":"11","author":"Q Kong","year":"2021","unstructured":"Kong Q, Ming W, Mi X-S (2021) Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis. BMJ Open 11:e042384","journal-title":"BMJ Open"},{"issue":"3","key":"2615_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0974-620X.142592","volume":"7","author":"PK Shah","year":"2014","unstructured":"Shah PK, Ramakrishnan M, Sadat B, Bachu S, Narendran V, Kalpana N (2014) Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity. Oman J Ophthalmol 7(3):116\u2013119","journal-title":"Oman J Ophthalmol"},{"key":"2615_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3928\/01913913-20101217-06","volume":"47","author":"KK Suk","year":"2010","unstructured":"Suk KK, Berrocal AM, Murray TG, Rich R, Major JC, Hess D et al (2010) Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 47:1\u20134","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2615_CR9","first-page":"Cd009734","volume":"1","author":"MJ Sankar","year":"2018","unstructured":"Sankar MJ, Sankar J, Chandra P (2018) Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev 1:Cd009734","journal-title":"Cochrane Database Syst Rev"},{"key":"2615_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","volume":"124","author":"DK Vander Veen","year":"2017","unstructured":"Vander Veen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR (2017) Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of ophthalmology. Ophthalmology 124:619\u2013633","journal-title":"Ophthalmology"},{"key":"2615_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) BEAT-ROP cooperative group efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603","journal-title":"N Engl J Med"},{"issue":"10","key":"2615_CR12","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A et al (2021) International classification of retinopathy of prematurity. Third Edition Ophthalmol 128(10):e51\u2013e68. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.031","journal-title":"Third Edition Ophthalmol"},{"key":"2615_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/bjo.84.9.963","volume":"84","author":"NE Schalij-Delfos","year":"2000","unstructured":"Schalij-Delfos NE, de Graaf ME, Treffers WF, Engel J, Cats BP (2000) Long-term follow up of premature infants: detection of strabismus, amblyopia, and refractive errors. Br J Ophthalmol 84:963\u2013967","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2615_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/cxo.12578","volume":"101","author":"MP Leung","year":"2018","unstructured":"Leung MP, Thompson B, Black J, Dai S, Alsweiler JM (2018) The effects of preterm birth on visual development. Clin Exp Optom 101(1):4\u201312","journal-title":"Clin Exp Optom"},{"key":"2615_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/aos.12053","volume":"91","author":"CS Yang","year":"2013","unstructured":"Yang CS, Wang AG, Shih YF, Hsu WM (2013) Long term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age. Acta Ophthalmol 91:276\u2013282","journal-title":"Acta Ophthalmol"},{"key":"2615_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/0301-4738.86306","volume":"59","author":"D Katoch","year":"2011","unstructured":"Katoch D, Sanghi G, Dogra MR, Beke N, Gupta A (2011) A structural sequelae and refractive outcome 1 year after laser treatment for type 1 pre-threshold retinopathy of prematurity in Asian Indian eyes. Indian J Ophthalmol 59:423\u2013426","journal-title":"Indian J Ophthalmol"},{"key":"2615_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3928\/01913913-20120207-02","volume":"49","author":"A Goktas","year":"2012","unstructured":"Goktas A, Sener EC, Sanac AS (2012) An assessment of ocular morbidities of children born prematurely in early childhood. J Pediatr Ophthalmol Strabismus 49:236\u2013241","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"11","key":"2615_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood E et al (2014) BEAT-ROP cooperative group refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol 132(11):1327\u201333","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"2615_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.ajo.2013.01.014","volume":"155","author":"BC Harder","year":"2013","unstructured":"Harder BC, Schlichtenbrede FC, von Baltz S, Jendritza W, Jendritza B, Jonas JB (2013) Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Am J Ophthalmol 155(6):1119\u20131124","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2615_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","volume":"122","author":"CK Hwang","year":"2015","unstructured":"Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR (2015) Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122(5):1008\u20131015","journal-title":"Ophthalmology"},{"issue":"5","key":"2615_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5935\/0004-2749.20150079","volume":"78","author":"M Gunay","year":"2015","unstructured":"Gunay M, Celik G, Gunay BO, Aktas A, Karatekin G, Ovali F (2015) Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity. Arq Bras Oftalmol 78(5):300\u2013304","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"2615_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaapos.2015.01.009","volume":"19","author":"M Isaac","year":"2015","unstructured":"Isaac M, Mireskandari K, Tehrani N (2015) Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser. J AAPOS 19(2):140\u2013144","journal-title":"J AAPOS"},{"issue":"4","key":"2615_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000439182","volume":"234","author":"HK Kuo","year":"2015","unstructured":"Kuo HK, Sun IT, Chung MY, Chen YH (2015) Refractive error in patients with retinopathy of prematurity after laser photocoagulation or bevacizumab monotherapy. Ophthalmologica 234(4):211\u2013217","journal-title":"Ophthalmologica"},{"issue":"7","key":"2615_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/02713683.2016.1264607","volume":"42","author":"EU Kabatas","year":"2017","unstructured":"Kabatas EU, Kurtul BE, Altiaylik Ozer P, Kabatas N (2017) Comparison of intravitreal bevacizumab, intravitreal ranibizumab and laser photocoagulation for treatment of type 1 retinopathy of prematurity in Turkish preterm children. Curr Eye Res 42(7):1054\u20131058","journal-title":"Curr Eye Res"},{"key":"2615_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bjo.81.1.2","volume":"81","author":"AR Fielder","year":"1997","unstructured":"Fielder AR, Quinn GE (1997) Myopia of prematurity: nature, nurture, or disease? Br J Ophthalmol 81:2\u20133","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2615_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/02713683.2016.1196709","volume":"42","author":"M Gunay","year":"2017","unstructured":"Gunay M, Sukgen EA, Celik G, Kocluk Y (2017) Comparison of bevacizumab, ranibizumab, and laser photocoagulation in the treatment of retinopathy of prematurity in Turkey. Curr Eye Res 42(3):462\u2013469","journal-title":"Curr Eye Res"},{"issue":"9","key":"2615_CR27","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ophtha.2005.03.025","volume":"112","author":"BV Davitt","year":"2005","unstructured":"Davitt BV, Dobson V, Good WV, Hardy RJ, Quinn GE, Siatkowski RM et al (2005) Early treatment for retinopathy of prematurity cooperative Group Prevalence of myopia at 9 months in infants with high-risk pre-threshold retinopathy of prematurity. Ophthalmology 112(9):1564\u20138","journal-title":"Ophthalmology"},{"key":"2615_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/eye.1997.188","volume":"11","author":"PM Pennefather","year":"1997","unstructured":"Pennefather PM, Tin W, Strong NP, Clarke MP, Dutton J, Cottrell DG (1997) Refractive errors in children born before 32 weeks gestation. Eye 11:736\u2013743","journal-title":"Eye"},{"issue":"2","key":"2615_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaapos.2020.01.007","volume":"24","author":"TL Lenis","year":"2020","unstructured":"Lenis TL, Gunzenhauser RC, Fung SSM, Dhindsa YK, Sarraf D, Pineles SL et al (2020) Myopia and anterior segment optical coherence tomography findings in laser-treated retinopathy of prematurity eyes. J AAPOS 24(2):86","journal-title":"J AAPOS"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02615-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02615-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02615-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:05:14Z","timestamp":1688137514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02615-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02615-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Health Science (2022\/01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}